Assessment of hepatic insulin degradation, in normoglycemic hypertensive patients, by minimal modelling of standard intravenous glucose tolerance test data

Computer Methods and Programs in Biomedicine

Volumn 97, Issue 2, 2010, Pages 189-198

  Di Nardo, Francesco ^a   Boemi, Massimo ^b   Burattini, Roberto ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INRCA   (Italy)

Author keywords

C peptide and insulin minimal model; Glucose metabolism; Indexes of cell responsiveness; Insulin resistance

Indexed keywords

C-PEPTIDE AND INSULIN MINIMAL MODEL; GLUCOSE METABOLISM; INSULIN RESISTANCE; MINIMAL MODEL;

DEGRADATION; GLUCOSE; IONIZING RADIATION; METABOLISM; PEPTIDES; PHYSIOLOGY; POPULATION STATISTICS;

INSULIN;

C PEPTIDE; GLUCOSE; INSULIN;

ADULT; AGE DETERMINATION; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN DEGRADATION; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; KINETICS; MALE; PANCREAS ISLET BETA CELL; SEX DETERMINATION; UPREGULATION;

BLOOD GLUCOSE; COMPUTER SIMULATION; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; HYPERTENSION; INSULIN; LIVER; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MODELS, BIOLOGICAL;

EID: 74649084401     PISSN: 01692607     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmpb.2009.08.007     Document Type: Article

References (28)

1. Ferrannini E., Buzzigoli G., Bonadonna R., Giorico M.A., Oleggini M., Graziadei L., Pedrinelli R., Brandi L., and Bevilacqua S. Insulin resistance in essential hypertension. N. Engl. J. Med. 317 (1987) 350-358
2. Kautzky-Willer A., Pacini G., Weissel M., Capek M., Ludvik B., and Prager R. Elevated hepatic insulin extraction in essential hypertension. Hypertension 21 (1993) 646-653
3. Natalucci S., Boemi M., Fumelli D., Fumelli P., and Burattini R. Interaction between glucose metabolism and endogenous insulin release in hypertension. Metabolism 51 (2002) 297-303
4. Reaven G.M. Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J. Clin. Endocrinol. Metab. 88 (2003) 399-2403
5. Burattini R., Di Nardo F., Boemi M., and Fumelli P. Deterioration of insulin sensitivity and glucose effectiveness with age and hypertension. Am. J. Hypertens. 19 (2006) 98-102
6. Ferrannini E., and Cobelli C. The kinetics of insulin in man. II. Role of the liver. Diabetes Metab. Rev. 3 (1987) 365-397
7. Cobelli C., Toffolo G.M., Dalla Man C., Campioni M., Denti P., Caumo A., Butler P., and Rizza R. Assessment of β-cell function in humans, simultaneously with insulin sensitivity and hepatic degradation, from intravenous and oral glucose tests. Am. J. Physiol. Endocrinol. Metab. 293 (2007) E1-E15
8. Toffolo G., De Grandi F., and Cobelli C. Estimation of beta-cell sensitivity from IVGTT C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion. Diabetes 44 (1995) 845-854
9. Toffolo G., Bergman R.N., Finegood D.T., Bowden C.R., and Cobelli C. Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. Diabetes 29 (1980) 979-990
10. M. Campioni, Models to assess insulin secretion, kinetics and hepatic degradation, Ph.D. Thesis, University of Padua, Italy, 2005.
11. Toffolo G., Campioni M., Rizza R., and Cobelli C. A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction. Am. J. Physiol. Endocrinol. Metab. 290 (2006) E169-E176
12. Van Cauter E., Mestrez F., Sturie J., and Polonsky K.S. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41 (1992) 368-377
13. Campioni M., Toffolo G., Rizza R., and Corbelli C. Estimation of hepatic insulin degradation during IM-IVGTT: individual vs standard kinetic parameters. Proc. of Medicon 2004, X Mediterranean Conf. on Med. and Biol. Eng. Ischia, Italy, July 31-August 5 (2004)
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA 285 (2001) 2486-2497.
15. Chen H., Sullivan G., Yue L.Q., Katz A., and Quon M.J. QUICKI is a useful index of insulin sensitivity in subjects with hypertension. Am. J. Physiol. Endocrinol. Metab. 284 (2003) E804-E812
16. Gress T.W., Nieto F.J., Shahar E., Wofford M.R., and Brancati F.L. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus, atherosclerosis risk in communities study. N. Engl. J. Med. 342 (2000) 905-912
17. Stas S., Appesh L., and Sowers J. Metabolic safety of antihypertensive drugs: myth versus reality. Curr. Hypertens. Rep. 8 (2006) 403-408
18. Bergman R.N., Ider Y.Z., Bowden C.R., and Cobelli C. Quantitative estimation of insulin sensitivity. Am. J. Physiol. 236 (1979) E667-E677
19. Eaton R.P., Allen R.C., Schade D.S., Erickson K.M., and Standfer J. Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behaviour. J. Clin. Endocrinol. Metab. 51 (1980) 520-528
20. Barrett P.H.R., Bell B.M., Cobelli C., Golde H., Schumitzky A., Vicini P., and Foster D.M. SAAM II: simulation, analysis, and modelling software for tracers and pharmacokinetics studies. Metabolism 47 (1998) 484-492
21. Carson E.R., Cobelli C., and Finkelstein L. The Mathematical Modeling of Metabolic and Endocrine Systems (1983), Wiley, New York, NY
22. Giugliano D., Quatraro A., Minei A., De Rosa N., Coppola L., and D'Onofrio F. Hyperinsulinemia in hypertension: increased secretion, reduced clearance or both?. J. Endocrinol. Invest. 16 (1993) 315-321
23. Basu R., Dalla Man C., Campioni M., Basu A., Klee G., Toffolo G., Cobelli C., and Rizza R.A. Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes 55 (2006) 2001-2014
24. Pacini G., Beccaro F., Valerio A., Nosadini R., and Crepaldi G. Reduced beta-cell secretion and insulin hepatic extraction in healthy elderly subjects. J. Am. Geriatr. Soc. 38 (1990) 1283-1289
25. Ahren B., and Pacini G. Age-related reduction in glucose elimination is accompanied by reduced glucose effectiveness and increased hepatic insulin extraction in man. J. Clin. Endocrinol. Metab. 83 (1998) 3350-3356
26. Cobelli C., and Pacini G. Insulin secretion and hepatic degradation in humans by minimal modeling of C-peptide and insulin data. Diabetes 37 (1988) 223-231
27. Pacini G., and Cobelli C. Estimation of beta-cell secretion and insulin hepatic degradation by the minimal modelling technique. Comput. Methods Programs Biomed. 32 (1990) 241-248
28. Cobelli C., Mari A., and Ferrannini E. On linearity of insulin kinetics. Am. J. Physiol. 251 (1986) E247-250